Dendritic Cells Pulsed with a Tumor-specific Peptide Induce Long-lasting Immunity and Are Effective against Murine Intracerebral Melanoma

This publication has 23 references indexed in Scilit:

• Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
  Nature Medicine, 2000
• Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
  Journal of Neuroimmunology, 2000
• Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors
  The Journal of Experimental Medicine, 1997
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
  The Journal of Experimental Medicine, 1996
• Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
  Science, 1993
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992
• Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.
  Proceedings of the National Academy of Sciences, 1992
• Lewis rat lymphoid dendritic cells can efficiently present homologous myelin basic protein to encephalitogenic lymphocytes
  Journal of Neuroimmunology, 1989
• Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.
  Proceedings of the National Academy of Sciences, 1988
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage
  European Journal of Immunology, 1981